Comments on: FDA expands approval for AbbVie’s Skyrizi for active psoriatic arthritis

Comments on: FDA expands approval for AbbVie’s Skyrizi for active psoriatic arthritis /news/fda-abbvie-skyrizi-arthritis/ The leading site for news and procurement in the pharmaceutical industry Mon, 24 Jan 2022 16:03:12 +0000 hourly 1 https://wordpress.org/?v=6.7.2